Drug | WT | Cyp2c/2d/3a KO | Cyp3a KO |
---|---|---|---|
Caffeine | |||
Cmax (µg/ml) | 3.11 ± 1.08 | 2.33 ± 0.19 | |
Half-life (min) | 71.3 ± 10.9 | 72.7 ± 25.0 | |
AUC0–8h (min⋅µg/ml) | 411.2 ± 43.3 | 351.8 ± 73.6 | |
AUC0–inf (min⋅µg/ml) | 415.4 ± 43.0 | 355.9 ± 72.6 | |
Cl (ml/min/kg) | 12.1 ± 1.33 | 14.7 ± 3.12 | |
Bupropion | |||
Cmax (µg/ml) | 0.74 ± 0.30 | 0.16 ± 0.02** | |
Half-life (min) | 72.3 ± 18.6 | 169.6 ± 53.6** | |
AUC0–8h (min⋅µg/ml) | 95.3 ± 26.3 | 12.1 ± 3.21*** | |
AUC0–nf (min⋅µg/ml) | 97.2 ± 26.8 | 13.2 ± 2.90*** | |
Cl (ml/min/kg) | 331.6 ± 106.8 | 2837 ± 805*** | |
Tolbutamide | |||
Cmax (µg/ml) | 54.2 ± 17.1 | 29.5 ± 14.1* | |
AUC0–8h (min⋅µg/ml) | 11,287 ± 2549 | 10,304 ± 2937 | |
Bufuralol | |||
Cmax (µg/ml) | 0.02 ± 0.01 | 0.30 ± 0.04*** | |
AUC0–8h (min⋅µg/ml) | 3.54 ± 2.13 | 93.1 ± 12.6*** | |
Midazolam | |||
Cmax (µg/ml) | 0.09 ± 0.03 | 0.30 ± 0.03** | 0.14 ± 0.06 |
Half-life (min) | 84.9 ± 12.1 | 81.5 ± 16.1 | 136 ± 89 |
AUC0–8h (min⋅µg/ml) | 7.31 ± 3.47 | 29.6 ± 11.1* | 14.2 ± 14.5 |
AUC0–inf (min⋅µg/ml) | 7.56 ± 3.46 | 30.2 ± 11.0* | 14.9 ± 14.5 |
Cl (ml/min/kg) | 469.7 ± 205.8 | 127.5 ± 57.7* | 366 ± 279 |
↵* P < 0.05; **P < 0.01; ***P < 0.005 WT to Cyp2c/2d/3a KO mice.